Beyond its well-documented roles, the BDNF Val66Met polymorphism has also been implicated in a range of cardiovascular diseases, inclusive of cardiometabolic disorders, coronary artery disease (CAD), and cardiomyopathy associated with Duchenne muscular dystrophy (DMD). This evidence concerns the gene BDNF and Duchenne muscular dystrophy.